AID Genomics Competitors and Similar CompaniesClear all

AID Genomics's competitors and similar companies include Guardant Health, Genetron Health, 2cureX and OmniSeq.

	AID Genomics AID Genomics is a group of medical technology companies specializing in the diagnosis and therapy of cancer.	Guardant Health Guardant Health is a company that specializes in non-invasive cancer diagnostics and comprehensive genomic liquid biopsy.	Genetron Health Genetron Health (北京泛生子基因科技有限公司, also known as Genetron Holdings) is a precision oncology platform company.	2cureX 2cureX is a biotech company that helps physicians to select an individual drug therapy for their cancer patients.	OmniSeq OmniSeq is a company that provides molecular diagnostic laboratory services.
Founding Date	Founding Date 2013	Founding Date 2012	Founding Date 2013	Founding Date 2006	Founding Date 2015
Type	Type Private	Type Public	Type Subsidiary	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech genetics medical diagnostics oncology therapy	Tags Healthcare biotech medical diagnostics oncology therapy	Tags Healthcare genetics medical diagnostics oncology therapy	Tags Healthcare biotech medical diagnostics oncology therapy	Tags Healthcare biotech genetics medical diagnostics oncology pharma therapy
Locations	Locations Rehovot, IL HQ	Locations Redwood City, US HQ	Locations Beijing, CN HQ Beijing, CN Chongqing, CN Guangzhou Shi, CN Hangzhou Shi, CN Shanghai, CN Durham, US see more	Locations Copenhagen, DK HQ Hamburg, DE	Locations Buffalo, US HQ
Employees	Employees 51	Employees 1,7681% decrease	Employees 993	Employees 14	Employees 26
Valuation ($)	Valuation ($) N/A	Valuation ($) 2.7 b	Valuation ($) N/A	Valuation ($) 792.7 k	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $982m (FY, 2025)	Revenue (est.) ¥650.7m (FY, 2022)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $349m (FY, 2025)	Cost of goods ¥324m (FY, 2022)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $633m (FY, 2025)	Gross profit ¥340.5m (FY, 2022)	Gross profit kr10k (FY, 2025)	Gross profit N/A
Net income	Net income N/A	Net income ($416.3m) (FY, 2025)	Net income (¥810.6m) (FY, 2022)	Net income (kr2.6m) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 550m	Total funding raised $ 132m	Total funding raised N/A	Total funding raised $ 11.6m